Pappas Capital is a venture capital firm with over 30 years of experience in investing in and building innovative companies within the life sciences sector. The firm has invested in more than 90 companies across the United States, Canada, and Asia, focusing on developing the next generation of life science products and technologies. Their portfolio includes companies that have brought treatments to market for conditions such as melanoma, ovarian cancer, and hemophilia, benefiting tens of thousands of patients worldwide and generating billions of dollars in revenue.

Pappas Capital is dedicated to furthering life science discoveries and bringing groundbreaking solutions to market.